...
机译:水痘-带状疱疹病毒对老年参与者的带状疱疹的特异性免疫反应在临床有效的带状疱疹疫苗试验中
1University of Colorado Denver;
2West Haven Cooperative Studies Program Coordinating Center, VA Connecticut Healthcare System, West Haven;
3VA San Diego Healthcare System and University of California, San Diego, and 4Cousins Center for Psychoneuroimmunology, University of California, Los Angeles;
5National Institutes of Health, Bethesda, Maryland;
6Merck Research Laboratories, West Point, Pennsylvania;
7Tufts University, Boston, Massachusetts;
8Columbia University, New York, New York;
9Veterans Administration (VA) Medical Center and University of Minnesota Medical School, Minneapolis;
10VA Ann Arbor Healthcare System and University of Michigan, Ann Arbor;
11Duke University Medical Center and Geriatric Research Education and Clinical Center, Durham VA Medical Center;
机译:在临床有效的带状疱疹疫苗试验中,老年参与者对带状疱疹的水痘带状疱疹病毒特异性免疫反应。
机译:带状疱疹疫苗的老年接受者中的水痘-带状疱疹病毒特异性免疫反应。
机译:水痘带状疱疹病毒-带状疱疹疫苗的老年人中的特定免疫反应。
机译:甲氨蝶呤对痘苗病毒,植物疱疹病毒(VZV),reoVirus ST3和单纯疱疹病毒(HSV-1)的抗病毒活性
机译:为潜在的水痘 - 带状疱疹病毒(VZV)的阶段为基础的HIV疫苗:在人类中vzV疫苗接种诱导的粘膜免疫应答的表征
机译:水痘-带状疱疹病毒对老年参与者的带状疱疹的特异性免疫反应在临床有效的带状疱疹疫苗试验中
机译:在临床有效的枢毛疫苗的试验中,Varicella-Zoster病毒特异性免疫应答对老年人参与者的疱疹疱疹